Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Teva forecasts worse-than-expected ‘trough year’ as generics hammer MS drug Copaxone

fiercepharmaFebruary 24, 2019

Tag: teva , worse-than-expected , generics hammer , MS drug Copaxone

PharmaSources Customer Service